The coronavirus disease 2019 (COVID-19) pandemic presented a significant challenge to health-care systems globally. The Saudi government took rapid and unprecedented precautionary measures to limit this disease's explosive spread. [1,2] Nevertheless, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) had infected almost 360,000 patients in Saudi Arabia by early December 2020. [3] This, in turn, jeopardized the ability of the health-care service to provide the required medical care for COVID-19 and non-COVID-19 patients. Cancer patients are more susceptible to infection than individuals without cancer because of the systemic immunosuppressive

No abstract